title: Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma.
authors.forename: Alfredo
authors.initials: A
authors.lastname: Berruti
authors.forename: Marcello
authors.initials: M
authors.lastname: Tucci
authors.forename: Carlo
authors.initials: C
authors.lastname: Terrone
authors.forename: Roberto Mario
authors.initials: RM
authors.lastname: Scarpa
authors.forename: Alberto
authors.initials: A
authors.lastname: Angeli
authors.forename: Luigi
authors.initials: L
authors.lastname: Dogliotti
mesh_terms: D000469:Alkaline Phosphatase / Q000187:drug effects / Q000378:metabolism*; D000728:Androgens / Q000378:metabolism*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000201:enzymology / Q000378:metabolism* / Q000556:secondary; D004164:Diphosphonates / Q000627:therapeutic use*; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D008297:Male; D010281:Parathyroid Hormone / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000201:enzymology / Q000378:metabolism* / Q000473:pathology; D016032:Randomized Controlled Trials as Topic; D000077211:Zoledronic Acid
chemical_list: D000728:Androgens; D000970:Antineoplastic Agents; D004164:Diphosphonates; D007093:Imidazoles; D010281:Parathyroid Hormone; D000077211:Zoledronic Acid; D000469:Alkaline Phosphatase